Factor IX studies at UCSF for GBT

Investigator: Matthew Jacobson, PhD
Sponsor: Global Blood Therapeutics, Inc

Location(s): United States


Factor IX studies at UCSF Global BioTherapeutic Technologies is a branch of Pfizer that does research in protein engineering. This research addresses factor IX, which is lacking in humans who have hemophila B. Pfizer has developed a recombanant version, BeneFIX, an antihemophilic factor.